Sector: Pharmaceuticals & Biotechnology
|Large Cap
Anthem Biosciences Ltd.
₹761.90
₹761.25
₹786.40
₹579.15
₹873.50
Markets Today
Historical Performance
Indicator | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 |
|---|---|---|---|---|---|
| Total Revenue | 582.50 | 416.58 | 552.23 | 538.01 | 478.98 |
| Operating Expense | 315.51 | 253.53 | 326.57 | 342.58 | 280.87 |
| Operating Profit | 266.99 | 163.05 | 225.66 | 195.43 | 198.11 |
| Depreciation | 26.28 | 26.75 | 23.92 | 22.61 | 20.99 |
| Interest | 1.58 | 1.13 | 2.23 | 1.61 | 2.10 |
| Tax | 89.06 | 37.98 | 54.87 | 50.60 | 90.28 |
| Net Profit | 211.66 | 112.12 | 198.43 | 148.34 | 122.56 |
₹761.90
↗ Bullish Moving Average
9
↘ Bearish Moving Average
7
| Held By | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|
| Promoter | 74.7 | 74.7 | 74.7 |
| FII | 1.7 | 1.4 | 1.3 |
| DII | 7.2 | 7.6 | 11.5 |
| Public | 16.4 | 16.3 | 12.5 |
| Period | Combined Delivery Volume | NSE+BSE Traded Volume Avg | Daily Avg Delivery Volume % |
|---|---|---|---|
| Day | 1.95 L | 3.65 L | 53.41% |
| Week | 4.01 L | 8 L | 50.15% |
| 1 Month | 2.82 L | 4.93 L | 57.22% |
| 6 Month | 4.28 L | 5.97 L | 71.72% |
Best results last week in YoY net profit and revenue growth
Benjamin Graham Value Screen
Stocks in Buy Zone with High Momentum Score Last Month
Buy Zone: Stocks in the buy zone based on days traded at current PE and P/BV
Relative Outperformance versus Industry over 1 Year
Companies with high TTM EPS Growth
Expensive Performers (DVM)
Annual Profit Growth higher than Sector Profit Growth
PEG lower than Industry PEG
Good Aggregate Candlestick Strength (total bullish - bearish candlesticks)
High Momentum Scores (Technical Scores greater than 50)
Good quarterly growth in the recent results
Effectively using its capital to generate profit - RoCE improving in last 2 years
Efficient in managing Assets to generate Profits - ROA improving since last 2 year
Growth in Net Profit with increasing Profit Margin (QoQ)
Growth in Quarterly Net Profit with increasing Profit Margin (YoY)
Companies with Low Debt
Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years
Annual Net Profits improving for last 2 years
Book Value per share Improving for last 2 years
Companies with Zero Promoter Pledge
Negative to Positive growth in Sales and Profit with Strong Price momentum
RSI indicating price strength
Stocks Outperforming their Industry Price Change in the Quarter
Ex-Date | Dividend Amount | Dividend Type | Record Date | Instrument Type |
|---|---|---|---|---|
| 25 Jun, 2026 | 2 | FINAL | 26 Jun, 2026 | Equity Share |
Financials | |||||
|---|---|---|---|---|---|
| Price (₹) | ₹1,176.10 | ₹1,800 | ₹1,739 | ₹2,459.50 | ₹179.75 |
| % Change | 5.59% | -1.88% | 1.48% | -0.80% | 2.35% |
| Revenue TTM (₹ Cr) | ₹2,192.49 | ₹1,421.59 | ₹9,203.54 | ₹14,277.64 | ₹8,869.07 |
| Net Profit TTM (₹ Cr) | ₹348.91 | ₹-73.80 | ₹924.36 | ₹1,912.93 | ₹-325.93 |
| PE TTM | 71.50 | -280.70 | 35.70 | 53.00 | -73.20 |
| 1 Year Return | 63.5 | 7.12 | 35.34 | 1.03 | -12.6 |
| ROCE | 18.38 | 0.59 | 25.65 | 14.32 | 2.29 |
Acutaas Chemicals Ltd.
₹ 2924.50
-0.90%
Gland Pharma Ltd.
₹ 2330.00
-0.17%
Laurus Labs Ltd.
₹ 1363.90
+1.52%
Alkem Laboratories Ltd.
₹ 5400.00
-0.08%
Biocon Ltd.
₹ 429.70
-0.13%
Divi's Laboratories Ltd.
₹ 6791.00
-1.39%
Ajanta Pharma Ltd.
₹ 3070.00
-1.21%
Zydus Lifesciences Ltd.
₹ 1071.50
+3.13%
Glenmark Pharmaceuticals Ltd.
₹ 2330.10
+3.14%
Wockhardt Ltd.
₹ 1645.00
+4.42%
Aurobindo Pharma Ltd.
₹ 1455.00
-0.58%
Natco Pharma Ltd.
₹ 1178.00
+0.71%
Sun Pharmaceutical Industries Ltd.
₹ 1844.00
-0.03%
Neuland Laboratories Ltd.
₹ 16763.00
+0.42%
Ipca Laboratories Ltd.
₹ 1565.20
-2.30%
J B Chemicals & Pharmaceuticals Ltd.
₹ 2233.60
+1.87%
AstraZeneca Pharma India Ltd.
₹ 8798.00
+2.45%
GlaxoSmithKline Pharmaceuticals Ltd.
₹ 2300.00
-0.30%
Pfizer Ltd.
₹ 4658.30
-0.27%
Abbott India Ltd.
₹ 27700.00
-0.47%
Torrent Pharmaceuticals Ltd.
₹ 4562.00
+1.69%
Lupin Ltd.
₹ 2291.00
+0.40%
Dr. Reddy's Laboratories Ltd.
₹ 1333.00
+1.97%
Cipla Ltd.
₹ 1414.60
+1.10%
By signing up I certify terms, conditions & privacy policy